枸橼酸氯米芬是改善特发性男性不育症的第一步:回顾性分析

IF 2.1 4区 医学 Q3 ANDROLOGY
Andrologia Pub Date : 2023-12-23 DOI:10.1155/2023/8743882
M. Manou Huijben, M. T. W. T. Tycho Lock, V. F. Vincent de Kemp, L. M. O. Laetitia de Kort, H. M. K. Jetske van Breda
{"title":"枸橼酸氯米芬是改善特发性男性不育症的第一步:回顾性分析","authors":"M. Manou Huijben,&nbsp;M. T. W. T. Tycho Lock,&nbsp;V. F. Vincent de Kemp,&nbsp;L. M. O. Laetitia de Kort,&nbsp;H. M. K. Jetske van Breda","doi":"10.1155/2023/8743882","DOIUrl":null,"url":null,"abstract":"<div>\n <p><i>Background</i>. Infertility in men is a common and worldwide problem with limited registered treatment options and licensed therapies. Clomiphene citrate (CC) is an empirical off-label therapy. CC is a selective estrogen receptor modulator that may improve testicular function, including sperm quality, by stimulating steroidogenesis and spermatogenesis. However, there is a lack of evidence regarding the efficacy of CC as therapy for male infertility. <i>Objectives</i>. To assess the improvement of CC on sperm parameters, pregnancy, hypogonadism, and measurement of safety. <i>Methods</i>. In this retrospective study, 52 men treated with CC for idiopathic nonobstructive infertility were analyzed. Data of sperm parameters, pregnancy rate, hormonal values, side effects, improvement in hypogonadal symptoms, and potential predictors of treatment response were collected. <i>Results</i>. A total of 52 infertile men underwent CC treatment. An increase in sperm concentration was observed in 19 patients (37%). An upgrade in sperm concentration classification according to the WHO criteria was noted in 21% of the patients receiving CC therapy. Additionally, 15% of initially ineligible patients for intrauterine insemination became eligible during CC. In total, 33% of couples achieved pregnancy, either spontaneously or with assisted reproductive techniques (ART). Low-normal follicle-stimulating hormone and larger testis volume before CC treatment were predictors for better semen concentration during treatment. The retrieval rate was 75% for azoospermic patients who underwent testicular sperm extraction or percutaneous epididymal sperm aspiration, enough for intracytoplasmic sperm injection. With CC, testosterone levels increased and hypogonadal symptoms improved. Mild side effects were reported by 8% of patients. <i>Conclusion</i>. The results of this study contribute to the existing evidence that CC is a safe and noninvasive therapy for idiopathic infertile males. It could be considered as a step-up therapy before initiating more invasive ART procedures.</p>\n </div>","PeriodicalId":7817,"journal":{"name":"Andrologia","volume":"2023 1","pages":""},"PeriodicalIF":2.1000,"publicationDate":"2023-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/2023/8743882","citationCount":"0","resultStr":"{\"title\":\"Clomiphene Citrate a First Step to Improve Idiopathic Male Infertility: A Retrospective Analysis\",\"authors\":\"M. Manou Huijben,&nbsp;M. T. W. T. Tycho Lock,&nbsp;V. F. Vincent de Kemp,&nbsp;L. M. O. Laetitia de Kort,&nbsp;H. M. K. Jetske van Breda\",\"doi\":\"10.1155/2023/8743882\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n <p><i>Background</i>. Infertility in men is a common and worldwide problem with limited registered treatment options and licensed therapies. Clomiphene citrate (CC) is an empirical off-label therapy. CC is a selective estrogen receptor modulator that may improve testicular function, including sperm quality, by stimulating steroidogenesis and spermatogenesis. However, there is a lack of evidence regarding the efficacy of CC as therapy for male infertility. <i>Objectives</i>. To assess the improvement of CC on sperm parameters, pregnancy, hypogonadism, and measurement of safety. <i>Methods</i>. In this retrospective study, 52 men treated with CC for idiopathic nonobstructive infertility were analyzed. Data of sperm parameters, pregnancy rate, hormonal values, side effects, improvement in hypogonadal symptoms, and potential predictors of treatment response were collected. <i>Results</i>. A total of 52 infertile men underwent CC treatment. An increase in sperm concentration was observed in 19 patients (37%). An upgrade in sperm concentration classification according to the WHO criteria was noted in 21% of the patients receiving CC therapy. Additionally, 15% of initially ineligible patients for intrauterine insemination became eligible during CC. In total, 33% of couples achieved pregnancy, either spontaneously or with assisted reproductive techniques (ART). Low-normal follicle-stimulating hormone and larger testis volume before CC treatment were predictors for better semen concentration during treatment. The retrieval rate was 75% for azoospermic patients who underwent testicular sperm extraction or percutaneous epididymal sperm aspiration, enough for intracytoplasmic sperm injection. With CC, testosterone levels increased and hypogonadal symptoms improved. Mild side effects were reported by 8% of patients. <i>Conclusion</i>. The results of this study contribute to the existing evidence that CC is a safe and noninvasive therapy for idiopathic infertile males. It could be considered as a step-up therapy before initiating more invasive ART procedures.</p>\\n </div>\",\"PeriodicalId\":7817,\"journal\":{\"name\":\"Andrologia\",\"volume\":\"2023 1\",\"pages\":\"\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2023-12-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1155/2023/8743882\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Andrologia\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1155/2023/8743882\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ANDROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Andrologia","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1155/2023/8743882","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ANDROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景。男性不育症是一个常见的世界性问题,但登记在册的治疗方案和许可疗法却很有限。枸橼酸氯米芬(CC)是一种经验性的非标签疗法。枸橼酸氯米芬是一种选择性雌激素受体调节剂,可通过刺激类固醇生成和精子生成来改善睾丸功能,包括精子质量。然而,目前还缺乏有关 CC 治疗男性不育症疗效的证据。研究目的评估CC对精子参数、妊娠、性腺功能减退症的改善情况,以及安全性测量。方法。在这项回顾性研究中,分析了 52 名接受 CC 治疗的特发性非梗阻性不育男性。收集了精子参数、妊娠率、激素值、副作用、性腺功能减退症状的改善情况以及治疗反应的潜在预测因素等数据。结果共有 52 名不育男性接受了 CC 治疗。19名患者(37%)的精子浓度有所提高。根据世界卫生组织的标准,21%接受CC治疗的患者的精子浓度分级有所提高。此外,15%最初不符合宫腔内人工授精条件的患者在接受CC治疗期间变得符合条件。共有 33% 的夫妇通过自然受孕或辅助生殖技术(ART)成功怀孕。CC治疗前低正常卵泡刺激素和较大的睾丸体积是治疗期间提高精液浓度的预测因素。接受睾丸取精术或经皮附睾精子抽吸术的无精子症患者的取精率为 75%,足以进行卵胞浆内单精子注射。使用 CC 后,睾酮水平有所提高,性腺功能减退的症状也有所改善。8%的患者报告了轻微的副作用。结论这项研究的结果为现有证据提供了依据,即CC是治疗特发性男性不育症的一种安全、非侵入性疗法。在启动更具侵入性的抗逆转录病毒疗法之前,可将其视为一种阶梯疗法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Clomiphene Citrate a First Step to Improve Idiopathic Male Infertility: A Retrospective Analysis

Clomiphene Citrate a First Step to Improve Idiopathic Male Infertility: A Retrospective Analysis

Background. Infertility in men is a common and worldwide problem with limited registered treatment options and licensed therapies. Clomiphene citrate (CC) is an empirical off-label therapy. CC is a selective estrogen receptor modulator that may improve testicular function, including sperm quality, by stimulating steroidogenesis and spermatogenesis. However, there is a lack of evidence regarding the efficacy of CC as therapy for male infertility. Objectives. To assess the improvement of CC on sperm parameters, pregnancy, hypogonadism, and measurement of safety. Methods. In this retrospective study, 52 men treated with CC for idiopathic nonobstructive infertility were analyzed. Data of sperm parameters, pregnancy rate, hormonal values, side effects, improvement in hypogonadal symptoms, and potential predictors of treatment response were collected. Results. A total of 52 infertile men underwent CC treatment. An increase in sperm concentration was observed in 19 patients (37%). An upgrade in sperm concentration classification according to the WHO criteria was noted in 21% of the patients receiving CC therapy. Additionally, 15% of initially ineligible patients for intrauterine insemination became eligible during CC. In total, 33% of couples achieved pregnancy, either spontaneously or with assisted reproductive techniques (ART). Low-normal follicle-stimulating hormone and larger testis volume before CC treatment were predictors for better semen concentration during treatment. The retrieval rate was 75% for azoospermic patients who underwent testicular sperm extraction or percutaneous epididymal sperm aspiration, enough for intracytoplasmic sperm injection. With CC, testosterone levels increased and hypogonadal symptoms improved. Mild side effects were reported by 8% of patients. Conclusion. The results of this study contribute to the existing evidence that CC is a safe and noninvasive therapy for idiopathic infertile males. It could be considered as a step-up therapy before initiating more invasive ART procedures.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Andrologia
Andrologia 医学-男科学
CiteScore
5.60
自引率
8.30%
发文量
292
审稿时长
6 months
期刊介绍: Andrologia provides an international forum for original papers on the current clinical, morphological, biochemical, and experimental status of organic male infertility and sexual disorders in men. The articles inform on the whole process of advances in andrology (including the aging male), from fundamental research to therapeutic developments worldwide. First published in 1969 and the first international journal of andrology, it is a well established journal in this expanding area of reproductive medicine.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信